Clinical role of positron emission tomography (PET) in endocrine tumours.

D Rubello, V Rufini, D Casara, ML Calcagni… - Panminerva …, 2002 - europepmc.org
Positron emission tomography (PET) is considered one of the most effective nuclear
medicine imaging modality in oncology. In many types of malignant tumours PET has proven …

[PDF][PDF] PET in Evaluation of Neuroendocrine Tumors

M Kuruva, T Bartel, S Osmany - rdcms-snmmi.s3.amazonaws.com
Neuroendocrine tumors (NETs) are distinctive tumors which arise from cells which have
neural and hormonal origins. The most common clinically-encountered NETs are …

Thyroid and Endocrine Tumors

M Eiber, F Gärtner, K Scheidhauer… - Atlas of PET/MR Imaging …, 2013 - Springer
In thyroid cancer 18 F-FDG is well established for detection of noniodine-avid disease in
patients with elevated Tg levels. From a prognostic perspective it is known that patients with …

[HTML][HTML] Nuclear medicine PET/CT thyroid cancer assessment, protocols, and interpretation

D Garcia, V Singh - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the role of PET/CT in the management of thyroid cancer. Review the
physiological basis behind radiotracer uptake in thyroid cancer subtypes. Summarize …

The Role of PET/CT in the Management of Differentiated Thyroid Cancer: Current Applications and Future Perspectives

E Panagiotidis, JT Zhang-Yin - 2024 - preprints.org
Differentiated thyroid cancer (DTC), comprising papillary and follicular thyroid carcinoma, is
the most common thyroid malignancy and typically has a favourable prognosis when …

PET/CT in the management of thyroid cancers

C Marcus, PW Whitworth, DS Surasi… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates
the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and …

How [18F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical Routines

J Vogel, J Sekler, B Gückel, C Pfannenberg… - Cancers, 2024 - mdpi.com
Simple Summary [18F] FDG-PET/CT is a new imaging modality used in routine practice for
many tumor diseases. The combination of morphological and metabolic information has …

Dual pathologies of parathyroid adenoma and papillary thyroid cancer on fluorocholine and fluorodeoxyglucose PET/CT

NTK Thanseer, SK Bhadada, A Sood… - Nuclear Medicine and …, 2018 - Springer
Abstract 18 F-Fluorocholine (FCH) PET/CT is evolving as a functional imaging modality for
the preoperative imaging of abnormal parathyroid tissue (s) helping to localize eutopic and …

Critical Role of 2-[18F]-fluoro-2-deoxy-glucose in Hormonally Active Malignancies

D Yadav, R Kumar - PET clinics, 2021 - pet.theclinics.com
PET has revolutionized the study of various biologic processes and opened new
possibilities in both fundamental research and the day-to-day practice of medicine …

[HTML][HTML] Staging of neuroendocrine tumours: comparison of [68Ga] DOTATOC multiphase PET/CT and whole-body MRI

C Schraml, NF Schwenzer, O Sperling, P Aschoff… - Cancer …, 2013 - ncbi.nlm.nih.gov
Purpose: In patients with a neuroendocrine tumour (NET), the extent of disease strongly
influences the outcome and multidisciplinary therapeutic management. Thus, systematic …